ErikaLee(Hedderick)FinangerMD

Child Neurology • Portland, OR

Professor of Pediatrics and Neurology

Join to view full profile

Dr. Finanger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Finanger's full profile

Already have an account?

Office
3181 Sw Sam Jackson Park Rd
Cdrc-P
Portland, OR 97239
Phone+1 503-494-5856

Fax+1 503-494-2370

Education & Training

Johns Hopkins UniversityFellowship, Neuromuscular Medicine (Neurology), 2008 - 2009
Johns Hopkins UniversityFellowship, Child Neurology, 2005 - 2008
Mayo Clinic College of MedicineClass of 2003

Certifications & Licensure

OR State Medical License 2009 - 2025
WA State Medical License 2023 - 2025
MD State Medical License 2008 - 2010
MN State Medical License 2004 - 2005
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine

Clinical Trials

A Study of Tadalafil for Duchenne Muscular Dystrophy Start of enrollment: 2013 Sep 01
Terminated
Phase 3
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy Start of enrollment: 2014 Aug 19
Terminated
Phase 3
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy Start of enrollment: 2015 Jun 30
Completed
Phase 2

Publications & Presentations

PubMed

1 citations
The recurrent deep intronic pseudoexon-inducing variantc.930+189C>T results in a consistently severe phenotype of COL6-related dystrophy: Towards clinical trial readin...
A Reghan Foley, Véronique Bolduc, Fady Guirguis, Sandra Donkervoort, Ying Hu
Medrxiv. 2024-03-29
2 citations
Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.
Lauren Jeffries, Emily K Mis, Kirsty McWalter, Sandra Donkervoort, Nina N Brodsky
Genetics in Medicine. 2024-02-01
1 citations
Clinical importance of changes in magnetic resonance biomarkers for Duchenne muscular dystrophy.
Rebecca J Willcocks, Alison M Barnard, Michael J Daniels, Sean C Forbes, William T Triplett
Annals of Clinical and Translational Neurology. 2024-01-01

Press Mentions

Local Girl Receives First at-Home Treatment for Rare DiseaseNovember 13th, 2020
Catabasis Pharmaceuticals Reports First Quarter 2020 Financial Results and Reviews Business ProgressMay 12th, 2020
Edasalonexent May Limit Disease Progression in Boys with Duchenne MD, Phase 1/2 Trial ShowsMarch 1st, 2019
Join now to see all